Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
Lakestar leads round with participation from existing investors Bessemer Venture Partners and 83North Vertice, the spend optimization platform, today announced $50 million in Series C funding led by Lakestar. This investment brings the total raised to over $100 million. Additional participants include Perpetual Growth and CF Private Equity, alongside existing investors…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
SMART Technologies and the University of Melbourne s collaborative research promise impactful ways to engage neurodivergent students. SMART Technologies, a global leader in interactive education technology, has partnered with the University of Melbourne to launch the first-of-its-kind research initiative exploring how classroom environments can better support neurodivergent learners. The study identified…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
- Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine - Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields The nomination period for the Broermann Medical Innovation Award has started. The prize, which…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
SEATTLE, WA, Jan 6, 2025 - (ACN Newswire) - Spectral Capital Corporation (OTCQB: FCCN), a pioneer in Quantum as a Service (QaaS) computing and decentralized cloud infrastructure, is pleased to announce the achievement of a major patent milestone as the first step in its plan to become a globally competitive…
![Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma](https://www.so-co-it.com/wp-content/themes/socoit20/timthumb.php?src=wp-content%2Fuploads%2F716035.jpg&q=90&w=260&h=260&zc=1%20width=260%20height=260)
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
Back to media releases (https://norgine.com/media) Next media release (https://norgine.com/press_release/norgine-receives-positive-chmp-opinion-recommending-approval-of-npj5008-dantrolene-sodium-hemiheptahydrate-for-the-treatment-of-malignant-hyperthermia/) Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, i…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
As part of the EU-funded APRIORA project, drug residues are being analysed. Scientists from the University of Rostock are taking water samples in all weathers. The aim is to use innovative approaches to improve wastewater treatment in Europe. The Warnow seems to be flowing uphill on this cold morning,…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
ZEISS Group revenue increased to just under 11 billion euros (10.894 billion euros), (up 8% on the prior year) – EBIT 1,444 million euros (prior year: 1,686 million euros, EBIT margin 13%). Mixed development in the segments. High spend on research and development equivalent to 15% of revenue, more than…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
- Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October 2024 by the Committee for Medicinal Products for Human…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
Lissi GmbH has qualified for the final phase of the EUDI-Wallet prototype competition organised by the German Federal Agency for Leap Innovation (SPRIND). The competition promotes innovative solutions for the implementation of the European eIDAS 2.0 regulation. “We are proud to have once again convinced the jury and to be…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
The akenza IoT platform announces the launch of akenza Building Edge, a powerful solution that bridges Building Management Systems (BMS) and the IoT, enabling intelligent, efficient, and sustainable building operations.…
